Cardiac syndrome X: Current concepts

International Journal of Cardiology

Volumn 142, Issue 2, 2010, Pages 113-119

  Singh, Mukesh ^a   Singh, Sarabjeet ^a   Arora, Rohit ^a   Khosla, Sandeep ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Angina; Cardiac syndrome X; Management; Pathophysiology

Indexed keywords

AMLODIPINE; ANTIANGINA PECTORIS AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILAZAPRIL; CONJUGATED ESTROGEN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METFORMIN; NICORANDIL; NIFEDIPINE; NISOLDIPINE; NITRATE; PROPRANOLOL; RAMIPRIL; STATIN; TRICYCLIC ANTIDEPRESSANT AGENT; VALSARTAN;

ANALGESIA; ANGIOGRAPHY; ARTERY CONSTRICTION; AUTONOMIC DYSFUNCTION; BEHAVIOR THERAPY; BLOOD FLOWMETRY; CEREBROVASCULAR MALFORMATION; CLINICAL TRIAL; COGNITIVE THERAPY; DIET; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ESTROGEN DEFICIENCY; EXERCISE; EXERCISE TEST; GROUP THERAPY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; HYPERACTIVITY; LIFESTYLE MODIFICATION; NOCICEPTION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SMOKING CESSATION; SPINAL CORD STIMULATION; SYNDROME X; TONOMETRY; WEIGHT REDUCTION;

ANIMALS; CARDIOVASCULAR AGENTS; CHEST PAIN; HUMANS; MICROVASCULAR ANGINA; RISK REDUCTION BEHAVIOR;

EID: 77953284701     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.11.021     Document Type: Review

References (106)

1. Betriu A., Pare J.C., Sanz G.A., et al. Myocardial infarction with normal coronary arteries: a prospective clinical-angiographic study. Am J Cardiol 48 (1981) 28-32
2. Lindsay J., and Pichard A.D. Acute myocardial infarction with normal coronary arteries. J Am Coll Cardiol 54 (1984) 902-903
3. Raymond R., Lynch J., Underwood D., Leatherman J., and Razavi. Acute myocardial infarction and normal coronary angiography 10 years clinical and risk analysis in 74 patients. J Am Coll Cardiol 11 (1988) 471-477
4. Kereiakes D.J., Topol E.J., George B.S., et al. Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion. J Am Coll Cardiol 17 (1991) 304-312
5. Lichtlen P.R., Bargheer K., and Wenzlaff P. Long term prognosis of patients with angina-like chest pain and normal coronary angiographic findings. J Am Coll Cardiol 25 (1995) 1013-1018
6. Kemp H.G., Kronmal R.A., Vliestra R.E., and Frye R.L. Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol 7 (1986) 479-483
7. Kemp H.G. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 32 (1973) 375-376
8. Merill C, Elixhauser A. Procedures in US Hospitals, 2003. Rockville, MD: Agency for Healthcare Research and Quality; 2005. HCUP Fact Book No 7. AHRQ Publication No. 06-0039. ISBN 1-58763-185-7.
9. Kaski JC, Russo G. Cardiac syndrome X: an overview. Hosp Pract (Off Ed). 2000;35(2):75-76, 79-82, 85-88 passim.
10. Kaski J.C., and Elliott P.M. Angina pectoris and normal coronary arteriograms: clinical presentation and hemodynamic characteristics. Am J Cardiol 76 (1995) 35D-42D
11. Beltrame J.F. Advances in understanding the mechanisms of angina pectoris in cardiac syndrome X. Eur Heart J 26 (2005) 946-948
12. Cannon III R.O., Camici P.G., Epstein S.E., et al. Pathophysiological dilemma of syndrome X. Circulation 85 (1992) 883-892
13. Kemp H.G. Syndrome X revisited. J Am Coll Cardiol 17 (1991) 507-508
14. Cannon III R.O., and Balaban R.S. Chest pain in women with normal coronary angiograms. N Engl J Med 342 (2000) 885-886
15. Likoff W., Segal B.L., Kasparian H., et al. Paradox of normal selective coronary angiograms in patients considered to have unmistakable coronary heart disease. N Engl J Med 276 (1967) 1063-1066
16. Arbogast R., and Bourassa M.G. Myocardial function during atrial pacing in patients with angina pectoris and normal coronary angiograms: comparison with patients having significant coronary artery disease. Am J Cardiol 32 (1973) 257-263
17. Cannon R.O., and Epstein S.E. «Microvascular angina» as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 62 (1988) 1338-1343
18. Kaski J.C., and Valenzuela Garcia L.F. Therapeutic options for the management of patients with cardiac syndrome X. Eur Heart J 22 (2001) 283-293
19. Turiel M., Galassi A.R., Glazier J.J., Kaski J.C., and Maseri A. Pain threshold and tolerance in women with syndrome X and women with stable angina pectoris. Am J Cardiol 60 (1987) 503-507
20. Galassi A.R., Kaski J.C., Crea F., et al. Heart rate response during exercise testing and ambulatory ECG monitoring in patients with syndrome X. Am Heart J 122 (1991) 458-463
21. Pupita G., Kaski J.C., Galassi A.R., Vejar M., Crea F., and Maseri A. Long-term variability of angina pectoris and electrocardiographic signs of ischemia in syndrome X. Am J Cardiol 64 (1989) 139-143
22. Kaski J.C., Crea F., Nihoyannopoulos P., Hackett D., and Maseri A. Transient myocardial ischemia during daily life in patients with syndrome X. Am J Cardiol 58 (1986) 1242-1247
23. Kaski J.C., Rosano G.M.C., Collins P., Nihoyannopoulos P., Maseri A., and Poole-Wilson P.A. Cardiac syndrome X: clinical characteristics and left ventricular function. Long term follow-up study. J Am Coll Cardiol 25 (1995) 807-814
24. Cannon R.O., Schenke W.H., Leon M.B., Rosing D.R., Urqhart J., and Epstein S.E. Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction. Circulation 75 (1987) 163-174
25. Bugiardini R., Badimon L., Collins P., et al. Angina, 'normal' coronary angiography, and vascular dysfunction: risk assessment strategies. P LoS Med 4 2 (2007) e12
26. Al Suwaidi J., Higano S.T., Holmes Jr. D.R., and Lerman A. Pathophysiology, diagnosis, and current management strategies for chest pain in patients with normal findings on angiography. Mayo Clin Proc 76 8 (2001) 813-822
27. Cannon R.O., Watson R.M., Rosing D.R., and Epstein S.E. Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol 1 (1983) 1359-1373
28. Panting J.R., Gatehouse P.D., Yang G.Z., et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 346 (2002) 1948-1953
29. Li J.J., Li Y.S., Zhang Y., Gao Z., Li Z., and Qian H.Y. Inflammation: a possible pathogenic link to cardiac syndrome X. Med Hypotheses 66 (2006) 87-91
30. Cannon R.O., Bonow R.O., Bacharach S.L., et al. Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries and abnormal vasodilator reserve. Circulation 71 (1985) 218-226
31. Maseri A., Crea F., Kaski J.C., and Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 17 (1991) 499-506
32. Lanza G.A., Sestito A., Cammarota G., et al. Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. Am J Cardiol 94 (2004) 40-44
33. Tousoulis D., Davies G.J., Asimakopoulos G., et al. Vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 serum level in patients with chest pain and normal coronary arteries (syndrome X). Clin Cardiol 24 (2001) 301-304
34. Cosin-Sales J., Pizzi C., Brown S., and Kaski J.C. C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary artery. J Am Coll Cardiol 41 (2003) 1468-1474
35. Teragawa H., Fukuda Y., Matsuda K., et al. Relation between C-reactive protein concentration and coronary microvascular endothelial function. Heart 90 (2004) 750-754
36. Dean J.D., Jones C.J., Hutchison S.J., Peters J.R., and Henderson A.H. Hyperinsulinaemia and microvascular angina ('syndrome X'). Lancet 337 (1991) 456-457
37. Botker H.E., Moller N., Ovesen P., et al. Insulin resistance in microvascular angina (syndrome X). Lancet 342 (1993) 136-140
38. Botker H.E., Frobert O., Moller N., Christiansen E., Schmitz O., and Bagger J.P. Insulin resistance in cardiac syndrome X and variant angina: influence of physical capacity and circulating lipids. Am Heart J 134 (1997) 229-237
39. Jadhav S., Ferrell W., Greer I.A., Petrie J.R., Cobbe S.M., and Sattar N. Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 48 (2006) 956-963
40. Rosen S.D., Paulesu E., Wise R.J.S., et al. Central neural contributing to the perception of chest pain in cardiac syndrome X. Heart 87 (2002) 513-519
41. Pasceri V., Lanza G.A., Buffon A., et al. Role of abnormal pain sensitivity and behavioral factors in determining chest pain in syndrome X. J Am Coll Cardiol 31 (1998) 62-66
42. Lanza G.A., Giordano A.G., Pristipino C., et al. Abnormal cardiac adrenergic never function in patient with syndrome X detected by [123] metaiodobenzylguanidine myocardial scintigraphy. Circulation 96 (1997) 821-826
43. Chauhan A., Mullins P.A., Thuraisingham S.I., Taylor G., Petch M.C., and Schofield P.M. Abnormal cardiac pain perception in syndrome X. J Am Coil Cardiol 24 (1994) 329-335
44. Shapiro L.M., Crake T., and Poole-Wilson P.A. Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries? Clinical observation during catheterisation. BMJ 296 (1988) 170-171
45. Cannon R.O., Quyyumi A.A., Schenke W.H., et al. Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol 16 (1990) 1359-1366
46. Rosano G.M., Collins P., Kaski J.C., Lindsay D.C., Sarrel P.M., and Poole-Wilson P.A. Syndrome X in women is associated with oestrogen deficiency. Eur Heart J 16 (1995) 610-614
47. Hayward C.S., Kelly R.P., and Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 46 1 (2000) 28-49
48. Roque M., Heras M., Roig E., et al. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms. J Am Coll Cardiol 31 (1998) 139-143
49. Albertsson P.A., Emanuelsson H., and Milsom I. Beneficial effect of treatment with transdermal estradiol-17-beta on exercise-induced angina and ST segment depression in syndrome X. Int J Cardiol 54 (1996) 13-20
50. Rosano G.M., Peters N.S., Lefroy D., et al. 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 28 (1996) 1500-1505
51. Fillingim R.B., and Maixner W. Gender differences in the responses to noxious stimuli. Pain Forum 4 (1995) 20921
52. Zubieta J.K., Smith Y.R., Bueller J.A., et al. Mu-opioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci 22 (2002) 51007
53. Lanza G.A., Manzoli A., Bia E., et al. Acute effects of nitrates on exercise testing in patients with syndrome X: clinical and pathophysiological implications. Circulation 90 (1994) 2695-2700
54. Bugiardini R., Manfrini O., Pizzi C., Fontana F., and Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation. 109 (2004) 2518-2523
55. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 26 5 (1995) 1235-1241
56. Bonetti P.O., Pumper G.M., Higano S.T., Holmes Jr. D.R., Kuvin J.T., and Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 44 11 (2004) 2137-2141
57. Kaski J.C. Pathophysiology and management of patients with chest pain and normal coronary angiograms (cardiac syndrome X). Circulation 109 (2004) 568-572
58. Kaski J.C., and Valenzuela Garcia L.F. Therapeutic options for the management of patients with cardiac syndrome X. Eur Heart J 22 (2001) 283-293
59. Eriksson B.E., Tyni-Lenne R., Svedenhag J., et al. Physical training in syndrome X: physical training counteracts deconditioning and pain in syndrome X. J Am Coll Cardiol. 36 5 (2000) 1619-1625
60. Raitakari O.T., Adams M.R., McCredie R.J., Griffiths K.A., and Celermajer D.S. Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. Ann Intern Med 130 7 (1999) 578-581
61. Gokce N., Vita J.A., McDonnell M., et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol 95 2 (2005) 266-268
62. Knoops K.T., de Groot L.C., Kromhout D., et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 292 12 (2004) 1433-1439
63. Lanza G.A., Colonna G., Pasceri V., and Maseri A. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol 84 (1999) 854-856
64. Bugiardini R., Borghi A., Biagetti L., et al. Comparison of verapamil versus propranolol therapy in syndrome X. Am J Cardiol 53 (1989) 286-290
65. Fragasso G., Chierchia S.L., Pizzetti G., et al. Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries: effects of β adrenergic blockade. Heart 77 (1997) 32-39
66. Madaric J., Bartunek J., Verhamme K., et al. Hyperdynamic myocardial response to beta-adrenergic stimulation in patients with chest pain and normal coronary arteries. J Am Coll Cardiol 46 (2005) 1270-1275
67. Crea F., and Lanza G.A. Angina pectoris and normal coronary arteries: cardiac syndrome X. Hear 90 4 (2004) 457-463
68. Ozcelik F., Altun A., and Ozbay G. Antianginal and anti-ischemic effects of nisoldipine and ramipril in patients with syndrome X. Clin Cardiol 22 (1999) 361-365
69. Montorsi P., Manfredi M., Loaldi A., et al. Comparison of coronary vasomotor responses to nifedipine in syndrome X and in Prinzmetal's angina pectoris. Am J Cardiol 63 (1989) 1198-1202
70. Lim T.K., Choy A.J., Khan F., Belch J.J., Struthers A.D., and Lang C.C. Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology. Cardiovasc Ther 27 1 (Spring 2009) 49-58
71. Ridker P.M., Cushman M., Stampfer M.J., et al. Inflammation, Aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
72. Nalbantgil I., Onder R., Altintig A., et al. Therapeutic benefits of cilazapril in patients with syndrome X. Cardiology 89 (1998) 130-133
73. Hirooka Y., Kimura Y., Sagara Y., Ito K., and Sunagawa K. Effects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertension. Clin Exp Hypertens 30 3 (Apr 2008) 267-276
74. Morimoto S., Maki K., Aota Y., Sakuma T., and Iwasaka T. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function. Hypertens Res 31 8 (Aug 2008) 1603-1610
75. Kayikcio M., Payzih S., Yavuzgil O., Kultursay H., Can L., and Soydan I. Benefits of statin treatment in cardiac syndrome X. Eur Heart J 24 (2003) 1999-2005
76. Rodríguez C., Alcudia J.F., Martínez-González J., et al. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors. Cardiovasc Res 83 3 (Aug 1 2009) 595-603
77. Chen Y.X., Wang X.Q., Fu Y., Yao Y.J., Kong M.Y., Nie R.Q., and Wang J.F. Pivotal role of inflammation in vascular endothelial dysfunction of hyperlipidemic rabbit and effects by atorvastatin. Int J Cardiol (Jun 30 2009) [Electronic publication ahead of print]. doi:10.1016/j.ijcard.2009.06.019
78. Mather K.J., Verma S., and Anderson T.J. Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol 37 (2001) 1344-1350
79. Jadhav S., Ferrell W., Greer I.A., Petrie J.R., Cobbe S.M., and Sattar N. Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 48 (2006) 956-963
80. Kapinya K., Nijjar P.S., Stanek M., and Amanullah A. Insulin-sensitizing antihyperglycaemic medications are associated with better outcome in patients with diabetes undergoing cardiac stress testing. Intern Med J. 38 4 (Apr 2008) 259-264
81. Asbury E.A., Creed F., and Collins P. Distinct psychosocial differences between women with coronary heart disease and cardiac syndrome X. Eur Heart J 25 (2004) 1695701
82. Adamson D.L., Webb C.M., and Collins P. Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms. Menopause 8 (2001) 23338
83. Sitges M., Heras M., Roig E., et al. Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries. Eur Heart J 22 (2001) 211624
84. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362 (2003) 41927
85. Magni G. The use of antidepressants in the treatment of chronic pain. Drugs 42 (1991) 730-748
86. Cox I., Hann C., Kaski J.C., et al. Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms. Eur Heart J 19 (1998) 250-254
87. Cannon III R.O., Quyyumi A.A., Mincemoyer R., et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 330 20 (1994) 1411-1417
88. Gibbons R.J., Abrams J., Chatterjee K., et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol. 41 (2003) 159-168
89. Johnson B.D., Shaw L.J., Buchthal S.D., et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 109 24 (2004) 2993-2999
90. Tousoulis D., Crake T., Lefroy D.C., et al. Left ventricular hypercontractility and ST segment depression in patients with syndrome X. J Am Coll Cardiol 22 (1993) 1607-1613
91. Chauhan A., Mullins P.A., Thuraisingham S.l., et al. Effect of transdermic electric nerve stimulation on coronary blood flow. Circulation 89 (1994) 694-702
92. Sanderson J.E., Woo K.S., Chung H.K., et al. The effect of transcutaneous electric nerve stimulation on coronary and systemic haemodynamics in syndrome X. Coron Artery Dis 7 (1996) 547-552
93. Eliasson T., Albertson P., Hardhammer P., et al. Spinal cord stimulation in angina pectoris with normal coronary angiograms. Coron Artery Dis 4 (1993) 819-827
94. Potts S.G., Lewin R., Fox K.A.A., et al. Group psychological treatment for chest pain with normal coronary arteries: a controlled trial. QJM 92 (1999) 81-86
95. Mayou R.A., Bryant B.M., Sanders D., et al. A controlled trial of cognitive behavioural therapy for non-cardiac chest pain. Psychol Med 27 (1997) 1021-1031
96. Van Peski-Oosterbaan A.S., Bruschke A.V., Rooijmans H.G., et al. Cognitive behavioural therapy for non-cardiac chest pain: a randomized trial. Am J Med 106 (1999) 424-429
97. Manchanda A., and Soran O. Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure. J Am Coll Cardiol 50 (2007) 1523-1531
98. Celik T., Iyisoy A., Yuksel U.C., and Amasyali B. A new treatment modality in management of patients with cardiac syndrome X: enhanced external counterpulsation. Int J Cardiol (2008) 10.1016/j.ijcard.2008.11.159
99. Bonetti P.O., Gadasalli S.N., Lerman A., and Barsness G.W. Successful treatment of symptomatic coronary endothelial dysfunction with enhanced external counterpulsation. Mayo Clin Proc 79 (2004) 690-692
100. Kronhaus K.D., and Lawson W.E. Enhanced external counterpulsation is an effective treatment for syndrome X. Int J Cardiol 135 2 (2009) 256-257
101. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 36 3 (2000) 970-1062
102. Opherk D., Schuler G., Wetterauer K., Manthey J., Schwartz F., and Kubler W. Four-year follow-up in patients with angina pectoris and normal coronary arteriograms ('syndrome X'). Circulation 80 (1989) 1610-1616
103. Cannon R.O., Dilsizian V., Correa R., Epstein S.E., and Bonow R.O. Chronic deterioration in left ventricular function in patients with microvascular angina. J Am Coll Cardiol 17 (1991) 28A abstract
104. Halcox J.P., Schenke W.H., Zalos G., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106 (2002) 653-658
105. Lamendola P., Lanza G.A., Spinelli A., Sgueglia G.A., Di Monaco A., Barone L., Sestito A., and Crea F. Long-term prognosis of patients with cardiac syndrome X. Int J Cardiol 140 (2010) 197-199
106. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150